Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001200158 | SCV001371047 | likely benign | not provided | 2020-05-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002560271 | SCV003454398 | likely benign | Brugada syndrome | 2024-10-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003163506 | SCV003860562 | uncertain significance | Cardiovascular phenotype | 2023-02-15 | criteria provided, single submitter | clinical testing | The c.1890G>A variant (also known as p.K630K), located in coding exon 13 of the SCN10A gene, results from a G to A substitution at nucleotide position 1890. This nucleotide substitution does not change the lysine at codon 630. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. The evidence for this gene-disease relationship is limited; therefore, the clinical significance of this alteration is unclear. |
Prevention |
RCV004545120 | SCV004776767 | likely benign | SCN10A-related disorder | 2019-08-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |